• SYNformulas, leading probiotics supplier from Germany, will exhibit for the first time at the pharmaceutical trade fair CPhI worldwide in Milan
• Focus will be on promoting internationalisation of business through partners under the Kijimea® brand or established local brand families
• Excellent, evidence-based products, supported by publications in e.g. The Lancet, generate worldwide interest
Gräfelfing, 25th October 2021. SYNformulas, one of the leading probiotics companies in the field of treating intestinal complaints and allergies, is e ...
Common diseases such as gastrointestinal conditions and allergies are the focus of the company’s research and product development. More value is being added for further licensing and distribution partners through strong scientific research results. SYNformulas is seeking for additional distribution partners to expand its internationalization activities with its patented active complexes.
SYNformulas, one of the leading probiotics companies in the field of treating gastrointestinal conditions and allergies with a focus on researching th ...